Endogenous Anandamide and Cannabinoid Receptor-2 Contribute to Electroacupuncture Analgesia in Rats

Journal of Pain

Volumn 10, Issue 7, 2009, Pages 732-739

  Chen, Lin ^a   Zhang, Jing ^a   Li, Fan ^a   Qiu, Yue ^a   Wang, Lu ^a   Li, Ying hua ^a   Shi, Jing ^a   Pan, Hui Lin ^b   Li, Man ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

acupuncture; analgesia; Anandamide; cannabinoid receptor 2 (CB2); hyperalgesia; inflammatory pain

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR;

ALLODYNIA; ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROACUPUNCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERALGESIA; INFLAMMATION; MALE; NONHUMAN; PAIN; RAT;

ANIMALS; ARACHIDONIC ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROACUPUNCTURE; FREUND'S ADJUVANT; HINDLIMB; HOT TEMPERATURE; HYPERALGESIA; INDOLES; MALE; PAIN; PHYSICAL STIMULATION; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SKIN;

EID: 67449141661     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2008.12.012     Document Type: Article

References (52)

1. Ahluwalia J., Urban L., Bevan S., and Nagy I. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur J Neurosci 17 (2003) 2611-2618
2. Beaulieu P., Bisogno T., Punwar S., Farquhar-Smith W.P., Ambrosino G., Di Marzo V., and Rice A.S. Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat. Eur J Pharmacol 396 (2000) 85-92
3. Beltramo M., Stella N., Calignano A., Lin S.Y., Makriyannis A., and Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277 (1997) 1094-1097
4. Bisogno T., Maurelli S., Melck D., De Petrocellis L., and Di Marzo V. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J Biol Chem 272 (1997) 3315-3323
5. Calignano A., La Rana G., Giuffrida A., and Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature 394 (1998) 277-281
6. Clayton N., Marshall F.H., Bountra C., and O'Shaughnessy C.T. CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain 96 (2002) 253-260
7. Cook C.D., and Moore K.I. Effects of sex, hindpaw injection site and stimulus modality on nociceptive sensitivity in arthritic rats. Physiol Behav 87 (2006) 552-562
8. da Fonseca Pacheco D., Klein A., de Castro Perez A., da Fonseca Pacheco C.M., de Francischi J.N., and Duarte I.D. The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors. Br J Pharmacol 154 (2008) 1143-1149
9. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
10. Du J. [The messengers from peripheral nervous system to central nervous system: Involvement of neurotrophins and cytokines in the mechanisms of acupuncture]. Zhen Ci Yan Jiu 33 (2008) 37-40
11. Elmes S.J., Jhaveri M.D., Smart D., Kendall D.A., and Chapman V. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain. Eur J Neurosci 20 (2004) 2311-2320
12. Felder C.C., Nielsen A., Briley E.M., Palkovits M., Priller J., Axelrod J., Nguyen D.N., Richardson J.M., Riggin R.M., Koppel G.A., Paul S.M., and Becker G.W. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett 393 (1996) 231-235
13. Galiegue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., and Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232 (1995) 54-61
14. Gatley S.J., Lan R., Pyatt B., Gifford A.N., Volkow N.D., and Makriyannis A. Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci 61 (1997) 191-197 PL
15. Giuffrida A., and Piomelli D. Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. FEBS Lett 422 (1998) 373-376
16. Guindon J., LoVerme J., De Lean A., Piomelli D., and Beaulieu P. Synergistic antinociceptive effects of anandamide, an endocannabinoid, and nonsteroidal anti-inflammatory drugs in peripheral tissue: A role for endogenous fatty-acid ethanolamides?. Eur J Pharmacol 550 (2006) 68-77
17. Han J.S. Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies. Trends Neurosci 26 (2003) 17-22
18. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
19. Hillard C.J., and Jarrahian A. The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chem Phys Lipids 108 (2000) 123-134
20. Horvath G., Kekesi G., Nagy E., and Benedek G. The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level. Pain 134 (2008) 277-284
21. Huang C., Huang Z.Q., Hu Z.P., Jiang S.Z., Li H.T., Han J.S., and Wan Y. Electroacupuncture effects in a rat model of complete Freund's adjuvant-induced inflammatory pain: antinociceptive effects enhanced and tolerance development accelerated. Neurochem Res 33 (2008) 2107-2111
22. Jubb R.W., Tukmachi E.S., Jones P.W., Dempsey E., Waterhouse L., and Brailsford S. A blinded randomised trial of acupuncture (manual and electroacupuncture) compared with a non-penetrating sham for the symptoms of osteoarthritis of the knee. Acupunct Med 26 (2008) 69-78
23. Kong J., Fufa D.T., Gerber A.J., Rosman I.S., Vangel M.G., Gracely R.H., and Gollub R.L. Psychophysical outcomes from a randomized pilot study of manual, electro, and sham acupuncture treatment on experimentally induced thermal pain. J Pain 6 (2005) 55-64
24. Li J.J., Chen R.M., Liu L., Wang S.Y., Yu P., Xie Y., Li M., and Shi J. [Effects of electroacupuncture on the immunoreactivity of focal cutaneous CB2 receptor positive cells in arthritis rats]. Zhen Ci Yan Jiu 32 (2007) 9-15
25. Liu F., Li J., Han Y., Yang Z.D., Xiao Y., Liu J., Li M., Peng B., Zhang J., Li L.L., and Shi J. [Effects of electroacupuncture on GDNF positive cell immunoreactivity in local dermal tissue of the inflammatory pain focus in the rat of adjuvant arthritis]. Zhongguo Zhen Jiu 26 (2006) 436-440
26. Maccarrone M., Di Rienzo M., Battista N., Gasperi V., Guerrieri P., Rossi A., and Finazzi-Agro A. The endocannabinoid system in human keratinocytes: Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem 278 (2003) 33896-33903
27. Mackie K. Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol 46 (2006) 101-122
28. Malan Jr. T.P., Ibrahim M.M., Deng H., Liu Q., Mata H.P., Vanderah T., Porreca F., and Makriyannis A. CB2 cannabinoid receptor-mediated peripheral antinociception. Pain 93 (2001) 239-245
29. Malan Jr. T.P., Ibrahim M.M., Vanderah T.W., Makriyannis A., and Porreca F. Inhibition of pain responses by activation of CB(2) cannabinoid receptors. Chem Phys Lipids 121 (2002) 191-200
30. Mechoulam R., Fride E., and Di Marzo V. Endocannabinoids. Eur J Pharmacol 359 (1998) 1-18
31. Morisset V., Ahluwalia J., Nagy I., and Urban L. Possible mechanisms of cannabinoid-induced antinociception in the spinal cord. Eur J Pharmacol 429 (2001) 93-100
32. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
33. Nackley A.G., Makriyannis A., and Hohmann A.G. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience 119 (2003) 747-757
34. Patel S., Rademacher D.J., and Hillard C.J. Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. J Pharmacol Exp Ther 306 (2003) 880-888
35. Pertwee R.G., and Ross R.A. Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 66 (2002) 101-121
36. Quartilho A., Mata H.P., Ibrahim M.M., Vanderah T.W., Porreca F., Makriyannis A., and Malan Jr. T.P. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology 99 (2003) 955-960
37. Rice A.S., Farquhar-Smith W.P., and Nagy I. Endocannabinoids and pain: Spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot Essent Fatty Acids 66 (2002) 243-256
38. Richardson J.D., Kilo S., and Hargreaves K.M. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75 (1998) 111-119
39. Ross R.A., Brockie H.C., Stevenson L.A., Murphy V.L., Templeton F., Makriyannis A., and Pertwee R.G. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. Br J Pharmacol 126 (1999) 665-672
40. Schmidt A., Brune K., and Hinz B. Determination of the endocannabinoid anandamide in human plasma by high-performance liquid chromatography. Biomed Chromatogr 20 (2006) 336-342
41. Singh Tahim A., Santha P., and Nagy I. Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons. Neuroscience 136 (2005) 539-548
42. Sokal D.M., Elmes S.J., Kendall D.A., and Chapman V. Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats. Neuropharmacology 45 (2003) 404-411
43. Stella N., Schweitzer P., and Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388 (1997) 773-778
44. Tognetto M., Amadesi S., Harrison S., Creminon C., Trevisani M., Carreras M., Matera M., Geppetti P., and Bianchi A. Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. J Neurosci 21 (2001) 1104-1109
45. Tsui P., and Leung M.C. Comparison of the effectiveness between manual acupuncture and electro-acupuncture on patients with tennis elbow. Acupunct Electrother Res 27 (2002) 107-117
46. Vas J., and White A. Evidence from RCTs on optimal acupuncture treatment for knee osteoarthritis: An exploratory review. Acupunct Med 25 (2007) 29-35
47. Vaughan C.W., and Christie M.J. Retrograde signalling by endocannabinoids. Handbook Exp Pharmacol 168 (2005) 367-383
48. Wang L., Zhang Y., Dai J., Yang J., and Gang S. Electroacupuncture (EA) modulates the expression of NMDA receptors in primary sensory neurons in relation to hyperalgesia in rats. Brain Res 1120 (2006) 46-53
49. Yung K.T. Birdcage model for the Chinese meridian system, VI: Meridians as the primary regulatory system. Am J Chin Med 33 (2005) 759-766
50. Zhang R.X., Lao L., Wang L., Liu B., Wang X., Ren K., and Berman B.M. Involvement of opioid receptors in electroacupuncture-produced anti-hyperalgesia in rats with peripheral inflammation. Brain Res 1020 (2004) 12-17
51. Zhao Z.Q. Neural mechanism underlying acupuncture analgesia. Prog Neurobiol 85 (2008) 355-375
52. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110